Corporate Governance. Opexa Therapeutics (NASDAQ:OPXA) is a biotechnology company dedicated to the development of patient-specific cellular therapies for the ...
Investor Relations · Why Invest · Press Releases ... Quick Links. Financial Reports · FAQs · Contact IR · About ... 281.872.8585. © 2017 Opexa Therapeutics, Inc.
Missing: opxa | Show results with:opxa
May 24, 2013 · Investor Relations. News Release Details ... [OPXA] to Ring The NASDAQ Stock Market Closing Bell ... [OPXA]:. Opexa's mission is to lead the field ...
Investor Relations. Cases. Currently there are no cases. Investigations. Title, Updated, Security. Opexa Therapeutics Inc (NASDAQ:OPXA) Investor Investigation ...
The Investor Relations website contains information about Armada Hoffler Properties, Inc.'s business for stockholders, potential investors, and financial ...
Missing: opxa | Show results with:opxa
Jul 3, 2017 · In conjunction with the proposed merger, an investor syndicate led by TVM Capital Life Sciences and comprised of existing Acer investors and new ...
Oct 2, 2014 · Opexa Therapeutics today announced that it will hold an Analyst and Investor Event in New York City, New York on Thursday, October 9, 2014.
Feb 7, 2013 · The 15th Annual BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies.
NEW: Experience our best charts yet. ; YTD Return, N/A ; Expense Ratio (net), N/A ; Category, N/A ; Last Cap Gain, N/A ; Morningstar Rating, N/A.
Missing: relations | Show results with:relations
Jan 28, 2016 · A live webcast of the company presentation can be accessed here, or via the Investor Relations section of the Company's website at www.